Arcutis Biotherapeutics Inc
NASDAQ:ARQT
| Market Cap (Intraday) | 1.76B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 100.07 |
| 10-Day MA | $14.29 |
| 50-Day MA | $13.98 |
| 200-Day MA | $12.93 |
Arcutis Biotherapeutics Inc Stock, NASDAQ:ARQT
3027 Townsgate Road, Suite 300, Westlake Village, California 91361
United States of America
Phone: +1.805.418.5006
Number of Employees: 342
Description
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.